1 September 2007   
 

CLSI 2008 Leadership Conference
2 – 4 April 2008
Renaissance Harborplace Hotel
Baltimore, Maryland USA

News
Executive Vice President's Message
Volunteer Focus
CLSI Volunteers Help Improve Tanzania’s Laboratories
CLSI Member Irwin Army Community Hospital Wins Laboratory of the Year Award
New Specimen Collection Quick Guides
Introducing Key to Quality Checklists
Announcement: New CLSI Catalog 2 - 2007
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Call for Nominations
Events and Exhibits
Upcoming Events
Upcoming Presentations
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
 
Winner of the Silver Award for Patient Education in the WWW Health Awards Program
 
Standards Status
Vote and Deadlines

Risk Management Techniques to Identify and Control Laboratory Error Sources (EP18-P2); Verification and Validation of Multiplex Nucleic Acid Assays (MM17-P); Interpretive Criteria for Microorganism Identification by DNA Target Sequencing (MM18-P)

CLSI submits the following for vote as a candidate-for-advancement consensus documents.  The documents and ballots are available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.  

EP18-P2Risk Management Techniques to Identify and Control Laboratory Error Sources
This guideline recommends risk management techniques that will aid in identifying, understanding, and managing sources of error (potential failure modes) and help to ensure correct results. It is targeted for those involved in supervision of laboratory-testing quality management, and it addresses issues related to specimen collection through reporting of results. The deadline for the completed ballot for EP18-P2 to be received at the CLSI offices is 23 October 2007.

MM18-PInterpretive Criteria for Microorganism Identification by DNA Target Sequencing
Sequencing of DNA targets of cultured isolates provides a quantitative metric within which to perceive microbial diversity, and can serve as the basis to identify microorganisms. This document is an effort to catalyze the entry of molecular microbiology into clinical usage by establishing interpretive criteria for microorganism identification. The deadline for the completed ballot for MM18-P to be received at the CLSI offices is 23 October 2007.

Second Notice

MM17-PVerification and Validation of Multiplex Nucleic Acid Assays
This guideline provides recommendations for analytic verification and validation of multiplex assays, as well as a review of different types of biologic and synthetic reference materials. The deadline for the completed ballot for MM17-P to be received at the CLSI offices is 28 September 2007.


Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership. [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2007 Clinical and Laboratory Standards Institute